Market Resilience: Unitedhealth Group Inc (UNH) Finishes Weak at 302.91, Down -1.56

Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.

Unitedhealth Group Inc (NYSE: UNH) closed the day trading at $302.91 down -1.56% from the previous closing price of $307.7. In other words, the price has decreased by -$1.56 from its previous closing price. On the day, 12.77 million shares were traded. UNH stock price reached its highest trading level at $303.6 during the session, while it also had its lowest trading level at $298.75.

Ratios:

For a better understanding of UNH, let’s look at its different ratios. In the meantime, Its Debt-to-Equity ratio is 0.86 whereas as Long-Term Debt/Eq ratio is at 0.75.

On May 21, 2025, HSBC Securities Downgraded its rating to Reduce which previously was Hold but kept the price unchanged to $270.

TD Cowen Downgraded its Buy to Hold on May 19, 2025, while the target price for the stock was maintained at $308.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 10 ’25 when Conway Patrick Hugh sold 589 shares for $305.00 per share. The transaction valued at 179,645 led to the insider holds 10,398 shares of the business.

Conway Patrick Hugh bought 589 shares of UNH for $179,645 on Jun 10 ’25. On May 16 ’25, another insider, REX JOHN F, who serves as the President & CFO of the company, bought 17,175 shares for $291.12 each. As a result, the insider paid 4,999,919 and bolstered with 203,796 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, UNH now has a Market Capitalization of 274781765632 and an Enterprise Value of 340111589376. As of this moment, Unitedhealth’s Price-to-Earnings (P/E) ratio for their current fiscal year is 12.66, and their Forward P/E ratio for the next fiscal year is 12.01. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 10.13. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.67 while its Price-to-Book (P/B) ratio in mrq is 2.90. Its current Enterprise Value per Revenue stands at 0.829 whereas that against EBITDA is 9.385.

Stock Price History:

The Beta on a monthly basis for UNH is 0.46, which has changed by -0.3994171 over the last 52 weeks, in comparison to a change of 0.12153554 over the same period for the S&P500. Over the past 52 weeks, UNH has reached a high of $630.73, while it has fallen to a 52-week low of $248.88. The 50-Day Moving Average of the stock is -6.84%, while the 200-Day Moving Average is calculated to be -37.68%.

Shares Statistics:

Over the past 3-months, UNH traded about 17.77M shares per day on average, while over the past 10 days, UNH traded about 11426790 shares per day. A total of 910.00M shares are outstanding, with a floating share count of 905.10M. Insiders hold about 0.22% of the company’s shares, while institutions hold 91.23% stake in the company. Shares short for UNH as of 1749772800 were 11746598 with a Short Ratio of 0.66, compared to 1747267200 on 11113473. Therefore, it implies a Short% of Shares Outstanding of 11746598 and a Short% of Float of 1.2999999.

Dividends & Splits

UNH’s forward annual dividend rate is 8.51, up from 8.4 a year ago. Against a Trailing Annual Dividend Yield of 0.027299315The stock’s 5-year Average Dividend Yield is 1.4. The current Payout Ratio is 52.75% for UNH, which recently paid a dividend on 2025-06-16 with an ex-dividend date of 1750032000. Stock splits for the company last occurred on 2005-05-31 when the company split stock in a 2:1 ratio.

Earnings Estimates

The firm’s stock currently is rated by 20.0 analysts. The consensus estimate for the next quarter is $5.15, with high estimates of $5.94 and low estimates of $4.01.

Analysts are recommending an EPS of between $26.0 and $19.58 for the fiscal current year, implying an average EPS of $22.15. EPS for the following year is $25.99, with 25.0 analysts recommending between $33.5 and $22.2.

Revenue Estimates

18 analysts predict $111.75B in revenue for the current quarter. It ranges from a high estimate of $115.54B to a low estimate of $110.02B. As of the current estimate, Unitedhealth Group Inc’s year-ago sales were $98.86BFor the next quarter, 18 analysts are estimating revenue of $113.52B. There is a high estimate of $116.38B for the next quarter, whereas the lowest estimate is $109.92B.

A total of 25 analysts have provided revenue estimates for UNH’s current fiscal year. The highest revenue estimate was $458.27B, while the lowest revenue estimate was $439.4B, resulting in an average revenue estimate of $449.58B. In the same quarter a year ago, actual revenue was $400.28BBased on 24 analysts’ estimates, the company’s revenue will be $478.48B in the next fiscal year. The high estimate is $490.48B and the low estimate is $454.05B.

Leave a Reply

Your email address will not be published. Required fields are marked *

DWinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.